<p>This is a $3,399,279.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Pediastent LLC, a minority-owned, woman-owned limited liability company, for the development leading to the commercialization of a bioresorbable stent for the treatment of coarctation of the aorta in neonates. The contract is a definitive, firm-fixed-price contract with a period of performance ending on March 22, 2022.</p>
<p>This is a $99,340 Firm Fixed Price contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Shechtman Dan under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for research and development of "Biodegradable Magnesium Stents with Fine Microstructure," which falls under the NHLBI's biomedical research portfolio. The contract was awarded on September 30, 2007 with a completion date of June 29, 2008.</p>
This is a federal contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Transmural Systems LLC, a woman-owned small business. The $2,999,984 Firm Fixed Price contract is for the development of a Transcatheter Cavopulmonary Bypass Endograft, which is a medical device to treat congenital heart disease. This contract was awarded as a Direct to Phase II Small Business Innovation Research (SBIR) project, indicating it builds upon prior SBIR-funded research...
This is a $3,399,609 Firm Fixed Price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Transmural Systems LLC, a woman-owned small business. The contract is for research and development of an "Intramyocardial Suture Annuloplasty System" under the NIH's Small Business Innovation Research (SBIR) program. This contract was set aside for total small business participation. Through past SBIR awards,...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Transmural Systems LLC, a woman-owned small business. The contract is for the development of a "Closure Devices for Transcaval Access to the Abdominal Aorta" under SBIR Topic 088. The contract has a ceiling value of $2,999,999.98 and was awarded on a firm fixed-price basis. Transmural Systems...
This $4,100,000.00 firm fixed-price contract was awarded by the National Institutes of Health (NIH) to Lymphatech, Inc., a minority-owned small business, under the Small Business Innovation Research (SBIR) program. The contract is for the development of an "ALL-IN-ONE PRESSURE, FLOW CONTROL, AND IMAGING FOR CULTURING AND MONITORING LYMPHATIC MICROPHYSIOLOGIC SYSTEM" to support the mission and objectives of the Advanced Research Projects Agency for Health (ARPA-H). The contract is set...
This is a $2,297,559.00 Firm Fixed Price contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Transmural Systems LLC, a woman-owned small business. The contract was awarded under the Small Business Innovation Research (SBIR) program, with a Topic 106 FAST-TRACK designation, for the development of an Active MRI Needle. Transmural Systems has previously received SBIR awards and grants from the National Institutes of Health and National Heart, Lung, and Blood...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $1,100,000.00 firm-fixed-price purchase order contract to Transmural Systems LLC, a woman-owned small business, for the manufacture of 200 Active Guidewires for MRI-guided cardiovascular catheterization. This contract is part of the National Heart, Lung, and Blood Institute's Division of Intramural Research's efforts to develop radiation-free heart catheterization...
This federal contract award, valued at $4,099,969.00, was granted by the National Institutes of Health (NIH) to Calyx Systems LLC, a small business entity, under the Small Business Innovation Research (SBIR) program of the Advanced Research Projects Agency for Health (ARPA-H). The contract is for the development of a "BioSmart" bioelectronic stent with electrochemical monitoring, acoustics, power recovery, and wireless telemetry capabilities. This award is part of the ARPA-H SBIR Topic...
This is a $3,299,988.00 Firm Fixed Price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH), to Transmural Systems LLC, a woman-owned small business. The contract is for a Small Business Innovation Research (SBIR) Phase I research project on a "CERCLAGE FOR TREATING SECONDARY MITRAL REGURGITATION". The contract was set aside for total small business participation and has an ultimate completion date of June 30,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Lyra Therapeutics Inc. for the development of a bioresorbable stent to treat coarctation of the aorta in neonates. The contract has a firm fixed price of $1,064,068.64 and is set to be completed by November 30, 2020. This SBIR contract is focused on the early-stage development and commercialization of the bioresorbable stent technology.